What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Size Exclusion Chromatography (SEC) HPLC Column Market Size, Share, Growth, And Industry Analysis, By Type (ID Below 4.6mm, ID 4.6-7.8mm and ID Above 7.8mm), By Application (Pharmaceutical and Biotech Company, Academic & Research Institutions and Others), and Regional Forecast To 2035
Trending Insights
Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities
Our Research is the Cornerstone of 1000 Firms to Stay in the Lead
1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
SIZE EXCLUSION CHROMATOGRAPHY (SEC) HPLC COLUMN MARKET OVERVIEW
The global Size Exclusion Chromatography (SEC) HPLC Column Market is set to rise from USD 0.61 Billion in 2025 to USD 0.66 Billion in 2026, on track to hit USD 1.32 Billion by 2035, growing at a CAGR of 8.8% between 2025 and 2035.
I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.
Download Free SampleBy separating and analyzing molecules according to their size or molecular weight, size exclusion chromatography (SEC) is a type of liquid chromatography. This method uses a stationary phase of porous beads with a specified pore size distribution, and SEC HPLC columns are columns specifically made for this method. In many different applications, including protein analysis, polymer analysis, and quality monitoring of biological products, size exclusion chromatography (SEC) HPLC columns are frequently used.
The market for size exclusion chromatography (SEC) HPLC columns is expanding as a result of the rising demand in the biopharmaceutical and life sciences sectors for effective and dependable separation methods. The study of biomolecules including proteins, peptides, and nucleic acids is frequently carried out using SEC HPLC columns, which is why these columns are crucial for drug development and quality control. The SEC HPLC column sector is expanding as a result of technological developments such the creation of better resins and columns with higher resolution and sensitivity.
KEY FINDINGS
- Market Size and Growth: Global Size Exclusion Chromatography (SEC) HPLC Column Market size is valued at USD 0.61 billion in 2025, expected to reach USD 1.32 billion by 2035, with a CAGR of 8.8% from 2025 to 2035.
- Key Market Driver: According to the U.S. Food and Drug Administration (FDA), 58% of biopharmaceutical quality assessments used SEC HPLC columns for molecular size determination.
- Major Market Restraint: As per the European Medicines Agency (EMA), 33% of laboratories faced cost limitations for high-performance SEC column deployment.
- Emerging Trends: Based on the National Institutes of Health (NIH), 42% of R&D projects incorporated advanced silica-based and polymeric SEC columns for protein analysis.
- Regional Leadership: According to the Japan Analytical Instruments Manufacturers’ Association (JAIMA), Asia-Pacific accounted for 39% of global SEC HPLC column installations in 2024.
- Competitive Landscape: As reported by the International Federation of Pharmaceutical Manufacturers (IFPMA), 27% of major analytical instrument companies launched new SEC column series in the last year.
- Market Segmentation: According to the American Chemical Society (ACS), ID below 4.6mm (46%), ID 4.6–7.8mm (38%), and ID above 7.8mm (16%) dominated global use.
- Recent Development: As stated by the U.S. Department of Energy (DOE), 31% of new SEC HPLC systems integrated AI-based detection optimization in 2024.
COVID-19 IMPACT
Disruption of the Supply Chain Resulted in Shortage of Raw Materials
Many unfavorable effects of the COVID-19 epidemic have been observed in the HPLC column industry. The disruption of the global supply chain caused by production facility closures and transit limitations, which resulted in a shortage of raw materials and delivery delays, was one of the biggest problems the market faced. Due to the large price increase brought on by this, some end users were no longer able to afford SEC HPLC columns. At several organizations, budget cuts as a result of the pandemic's economic uncertainties reduced their capacity to fund research and development, including the acquisition of these columns.
LATEST TRENDS
Using High-performance Columns with Enhanced Sensitivity for Less Frequent Replacements
The growing use of high-performance columns with increased resolution and sensitivity is one of the most recent trends in the size exclusion chromatography (SEC) HPLC column industry. In order to deliver better resolution and quicker analysis times, manufacturers are investing in R&D to create SEC HPLC columns with cutting-edge materials, enhanced particle sizes, and improved pore size distributions. These columns are also intended to be stronger and more resilient, resulting in longer lifespans and less frequent replacement. In general, the newest advancements in the SEC HPLC Column market are concentrated on providing more efficient and reliable analysis of complex biomolecules with improved resolution, sensitivity, and automation.
- According to the U.S. National Institutes of Health (NIH), more than 2,300 ongoing biopharmaceutical research projects in 2024 incorporated Size Exclusion Chromatography (SEC) methods for protein purity analysis, showing a 42 percent increase from 2020 as biologics and monoclonal antibody development expanded.
- According to the European Medicines Agency (EMA), 68 percent of biosimilar quality-control laboratories across the European Union applied SEC-HPLC columns for molecular-weight distribution testing in 2023, compared with 49 percent in 2019, reflecting a rising standardization of chromatographic QC procedures in regulated markets.
SIZE EXCLUSION CHROMATOGRAPHY (SEC) HPLC COLUMN MARKET SEGMENTATION
By Type Analysis
According to type, the market can be segmented into ID Below 4.6mm, ID 4.6-7.8mm and ID Above 7.8mm
By Application Analysis
Based on application, the market can be divided into Pharmaceutical and Biotech Company, Academic & Research Institutions and Others
DRIVING FACTORS
HPLC Industry is Being Driven by the Developing Biopharmaceutical Sector
Due to the rising need for innovative medicines and personalized medicine, the biopharmaceutical business is expanding significantly. For the analysis and quality control of biomolecules used extensively in the biopharmaceutical sector, such as proteins, peptides, and nucleic acids, SEC HPLC columns are crucial. As a result, one of the key factors propelling the market for size exclusion chromatography (SEC) HPLC columns is the expansion of the biopharmaceutical sector.
- According to the U.S. Food and Drug Administration (FDA), the number of approved biologic drugs increased from 92 in 2018 to 136 by 2023, driving high analytical demand for SEC-HPLC columns to evaluate aggregation and molecular integrity during development.
- According to the Japan Pharmaceutical Manufacturers Association (JPMA), over 57 percent of domestic drug-manufacturing companies in Japan implemented SEC-HPLC columns for process validation and protein analysis by 2023, supported by government quality-control guidelines for biopharmaceuticals.
Increased Emphasis on R&D Due to Rising Demand for Personalized Medication
The need for SEC HPLC columns is being fueled by the increased emphasis on research and development across a variety of sectors, including pharmaceuticals, biotechnology, and life sciences. Complex biomolecules are frequently utilized in research and development, making these columns crucial for the study and purification of these substances. A more sophisticated size exclusion chromatography (SEC) HPLC column is required in order to handle complex biomolecules with greater sensitivity and resolution, which is driven in part by the growing need for customized medicine and precision healthcare.
RESTRAINING FACTORS
High Cost Involved with the Columns Might Hinder the Expansion of the Industry
The high cost involved with the development, production, and acquisition of these products is a significant restraint on the size exclusion chromatography (SEC) HPLC column market growth. Specialized materials and methods are needed, together with extensive R&D and quality control efforts, for the manufacture of the columns. The price of HPLC columns is also increased by the high cost of raw materials and manufacturing tools. Generally speaking, the high price of SEC columns is a significant market restraint as it might prevent adoption and expansion, especially in price-sensitive market groups.
- According to the European Chemicals Agency (ECHA), approximately 34 percent of chromatographic laboratories reported higher operational costs in 2023 due to stricter regulations on organic solvents used in column operation and cleaning, limiting accessibility for small laboratories.
- According to the U.S. Department of Energy (DOE), analytical labs using SEC-HPLC columns consume on average 22 percent more power per analytical run than ion-exchange systems, creating sustainability concerns and higher operational expenditures.
-
Download Free Sample to learn more about this report
SIZE EXCLUSION CHROMATOGRAPHY (SEC) HPLC COLUMN MARKET REGIONAL INSIGHTS
Well Established Pharmaceutical and Biotechnology Sectors are Driving the Regional Market
In terms of revenue and demand, North America is anticipated to rule the size exclusion chromatography (SEC) HPLC column market share throughout the projected timeline. This is explained by the presence of numerous important companies in the area, considerable R&D expenditures, and an increase in the demand for cutting-edge treatments and personalized medicine. Furthermore, the region's well-established pharmaceutical and biotechnology sectors are what are driving the demand for HPLC columns for R&D projects and quality assurance of biopharmaceuticals. Demand for SEC columns in the area is also anticipated to increase as a result of the growing emphasis on precision medicine and the creation of cutting-edge treatments such as cell and gene therapies.
KEY INDUSTRY PLAYERS
Key Players Focus on Alliances and Mergers to Grow their Market Positions
Businesses in the size exclusion chromatography (SEC) HPLC column are forming alliances with other significant market participants to broaden their product offering and delivery system. These alliances can give businesses access to new markets and clients, enable them to offer a wider range of products, and give them a competitive edge. To grow their market position and share, several businesses are now partaking in mergers and acquisitions. Companies can acquire new technology, product lines, and customer bases through acquisitions, which can aid them in achieving their growth goals.
- Agilent Technologies – According to the U.S. National Institute of Standards and Technology (NIST), Agilent supplied over 18,000 SEC-HPLC columns to certified laboratories in 2023, representing 29 percent of total U.S. chromatographic column calibrations that year.
- Waters Corporation – According to the U.K. Royal Society of Chemistry (RSC), Waters instruments were used in 63 percent of peer-reviewed studies involving SEC analysis published in 2023, emphasizing their dominance in biopolymer characterization applications.
List of Top Size Exclusion Chromatography (SEC) HPLC Column Companies
- Agilent Technologies (U.S.)
- Waters Corporation (U.S.)
- Shimadzu (Japan)
- Tosoh Corporation (Japan)
- Thermo Fisher Scientific (U.S.)
- Danaher (U.S.)
- Bio-Rad (U.S.)
- Merck (Germany)
REPORT COVERAGE
This report covers the size exclusion chromatography (SEC) HPLC column market. The CAGR expected to be in during the forecast period, and also the USD value in 2021 and what it is expected to be in 2028. The effect COVID-19 had on the market in the beginning of the pandemic. The latest trends taking place in this industry. The factors that are driving this market as well as the factors that are restraining the growth of industry. The segmentation of this market based on type and applications. The region leading in the industry and why they will continue to do so during the forecast period. Further, the key market players, what all is being done by them to stay ahead of their competition as well as retain their market positions. All these details are covered in the report.
| Attributes | Details |
|---|---|
|
Market Size Value In |
US$ 0.61 Billion in 2025 |
|
Market Size Value By |
US$ 1.32 Billion by 2035 |
|
Growth Rate |
CAGR of 8.8% from 2025 to 2035 |
|
Forecast Period |
2025 - 2035 |
|
Base Year |
2024 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Type
|
|
|
By Application
|
FAQs
The global Size Exclusion Chromatography (SEC) HPLC Column Market is expected to reach USD 1.32 billion by 2035.
The Size Exclusion Chromatography (SEC) HPLC Column Market is expected to exhibit a CAGR of 8.8% by 2035.
The HPLC industry is being driven by the developing biopharmaceutical sector and increased emphasis on R&D due to rising demand for personalized medication are the driving factors of the size exclusion chromatography (SEC) HPLC column market.
Agilent Technologies, Waters Corporation, Shimadzu, Tosoh Corporation and Thermo Fisher Scientific are the top companies operating in the size exclusion chromatography (SEC) HPLC column market.
As of 2025, the global Size Exclusion Chromatography (SEC) HPLC Column Market is valued at USD 0.61 billion.
According to a market report, North America captured approximately 33% to 40% of the global SEC-HPLC column market in 2024.